Department of Pharmacology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland.
Department of Pharmacology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Jordana 38 St., 41-808, Zabrze, Poland.
Cardiovasc Diabetol. 2023 Nov 28;22(1):323. doi: 10.1186/s12933-023-02059-0.
An obesity paradox has been described in relation to adverse clinical outcomes (e.g., mortality) with lower body mass index (BMI).
We sought to evaluate the association between BMI and weight loss with long-term all-cause mortality in adult populations under the care of family physicians.
LIPIDOGRAM studies were conducted in primary care in Poland in 2004, 2006, and 2015 and enrolled a total of 45,615 patients. The LIPIDOGRAM Plus study included 1627 patients recruited in the LIPIDOGRAM 2004 and repeated measurements in 2006 edition. Patients were classified by BMI categories as underweight, normal weight, overweight and class I, II, or III (obesity). Follow-up data up to December 2021 were obtained from the Central Statistical Office. Differences in all-cause mortality were analyzed using Kaplan‒Meier and Cox regression analyses.
Of 45,615 patients, 10,987 (24.1%) were normal weight, 320 (0.7%) were underweight, 19,134 (41.9%) were overweight, and 15,174 (33.2%) lived with obesity. Follow-up was available for 44,620 patients (97.8%, median duration 15.3 years, 61.7% females). In the crude analysis, long-term all-cause mortality was lowest for the normal-weight group (14%) compared with other categories. After adjusting for comorbidities, the highest risk of death was observed for the class III obesity and underweight categories (hazard ratio, HR 1.79, 95% CI [1.55-2.05] and HR 1.57, 95% CI [1.22-2.04]), respectively. The LIPIDOGRAM Plus analysis revealed that a decrease in body weight (by 5 and 10%) over 2 years was associated with a significantly increased risk of death during long-term follow-up-HR 1.45 (95% CI 1.05-2.02, p = 0.03) and HR 1.67 (95% CI 1.02-2.74, p < 0.001). Patients who experienced weight loss were older and more burdened with comorbidities.
Being underweight, overweight or obese is associated with a higher mortality risk in a population of patients in primary care. Patients who lost weight were older and more burdened with cardiometabolic diseases, which may suggest unintentional weight loss, and were at higher risk of death in the long-term follow-up. In nonsmoking patients without comorbidities, the lowest mortality was observed in those with a BMI < 25 kg/m, and no U-curve relationship was observed.
在与不良临床结局(如死亡率)相关的情况下,已经描述了肥胖悖论与较低的体重指数(BMI)有关。
我们旨在评估在家庭医生护理下的成年人群中,BMI 和体重减轻与长期全因死亡率之间的关系。
在波兰的初级保健中进行了 LIPIDOGRAM 研究,分别于 2004 年、2006 年和 2015 年进行,共纳入了 45615 名患者。LIPIDOGRAM Plus 研究包括在 LIPIDOGRAM 2004 年招募的 1627 名患者和 2006 年版的重复测量。患者根据 BMI 类别分为体重不足、正常体重、超重和 I、II 或 III 类(肥胖)。截至 2021 年 12 月,从中央统计局获得了随访数据。使用 Kaplan-Meier 和 Cox 回归分析来分析全因死亡率的差异。
在 45615 名患者中,10987 名(24.1%)为正常体重,320 名(0.7%)为体重不足,19134 名(41.9%)为超重,15174 名(33.2%)患有肥胖症。44620 名患者(97.8%,中位随访时间为 15.3 年,女性占 61.7%)可获得随访数据。在粗分析中,与其他类别相比,正常体重组的长期全因死亡率最低(14%)。在调整合并症后,观察到肥胖症 III 类和体重不足类别的死亡风险最高(风险比,HR 1.79,95%CI [1.55-2.05]和 HR 1.57,95%CI [1.22-2.04])。LIPIDOGRAM Plus 分析显示,体重在 2 年内减轻 5%和 10%与长期随访期间死亡风险显著增加相关-HR 1.45(95%CI 1.05-2.02,p=0.03)和 HR 1.67(95%CI 1.02-2.74,p<0.001)。体重减轻的患者年龄更大,合并症负担更重。
在初级保健患者人群中,体重不足、超重或肥胖与更高的死亡率风险相关。体重减轻的患者年龄更大,合并的心血管代谢疾病负担更重,这可能提示无意识的体重减轻,并且在长期随访中死亡风险更高。在无合并症的不吸烟患者中,BMI<25 kg/m2 时观察到的死亡率最低,并且未观察到 U 型曲线关系。